Title: A Phase I Study with an Expansion Cohort of the Combination of Ipilimumab and Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Hodgkin Lymphoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4412 Arms D and E)

BLOOD

AMER SOC HEMATOLOGY

1. Seattle Genetics
2. BMS
3. Merck
4. Genentech
5. Molecular Templates
6. Oncomed
7. National Cancer Institute of the National Institutes of Health
8. Celgene
9. Janssen
10. Regeneron
11. Agensys
12. Pharmacyclics
13. Infinity
14. Millennium
15. Celldex